Shopping Cart
Remove All
Your shopping cart is currently empty
CRTh2 antagonist 3 is a powerful chemokine receptor homologous molecule expressed on Th2 cell (CRTh2) antagonists. CRTh2 antagonist 3 enhanced the activity of PDK1 on short peptide substrates with EC50 of 2 μM and Kd of 8.4 μM. CRTh2 antagonist 3 has the potential to cause cardiovascular inflammation.


| Description | CRTh2 antagonist 3 is a powerful chemokine receptor homologous molecule expressed on Th2 cell (CRTh2) antagonists. CRTh2 antagonist 3 enhanced the activity of PDK1 on short peptide substrates with EC50 of 2 μM and Kd of 8.4 μM. CRTh2 antagonist 3 has the potential to cause cardiovascular inflammation. |
| Targets&IC50 | PDK1:2 μM (EC50), PDK1:8.4 μM (Ki) |
| In vitro | CRTh2 antagonist 3 is a small molecule allosteric modulator of structure-based docking protein kinase PDK1. CRTh2 antagonist 3 is 5 times more potent than its parent compound. |
| Molecular Weight | 356.44 |
| Formula | C19H20N2O3S |
| Cas No. | 312928-72-6 |
| Relative Density. | 1.26 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.